 The study found that RSV is a major cause of respiratory illnesses in young children in Kenya, especially those under six months old. It also showed that there are high rates of hospitalized and non-hospitalized severe RSV-associated illnesses and deaths. This suggests that prioritizing development and use of maternal vaccines and affordable long-lasting monoclonal antibodies could help reduce the burden of RSV infections in Kenya. This article was authored by Brian O'Newanda, Nixon Mironga, Nancy Aotieno and others.